APA (7th ed.) Citation

C, P., A, G., S, M., F, P., L, T., M, S., . . . F, B. (2026). Pharmacotherapy options and drug development in bronchiectasis: Spotlight on dipeptidyl-peptidase inhibitors. Expert opinion on pharmacotherapy, 27(6), 521. https://doi.org/10.1080/14656566.2026.2664617

Chicago Style (17th ed.) Citation

C, Premuda, Gramegna A, Misuraca S, Piedepalumbo F, Terranova L, Santambrogio M, Contarini M, Ori M, and Blasi F. "Pharmacotherapy Options and Drug Development in Bronchiectasis: Spotlight on Dipeptidyl-peptidase Inhibitors." Expert Opinion on Pharmacotherapy 27, no. 6 (2026): 521. https://doi.org/10.1080/14656566.2026.2664617.

MLA (9th ed.) Citation

C, Premuda, et al. "Pharmacotherapy Options and Drug Development in Bronchiectasis: Spotlight on Dipeptidyl-peptidase Inhibitors." Expert Opinion on Pharmacotherapy, vol. 27, no. 6, 2026, p. 521, https://doi.org/10.1080/14656566.2026.2664617.